N-[(3aR,6aS)-5,5-dioxo-3-[(1S)-1-phenylethyl]-3a,4,6,6a-tetrahydrothieno[3,4-d][1,3]thiazol-2-ylidene]butanamide

C17H22N2O3S2 — CID 92670087

IUPACN-[(3aR,6aS)-5,5-dioxo-3-[(1S)-1-phenylethyl]-3a,4,6,6a-tetrahydrothieno[3,4-d][1,3]thiazol-2-ylidene]butanamide
SMILESCCCC(=O)/N=C1\S[C@@H]2CS(=O)(=O)C[C@H]2N1[C@@H](C)c1ccccc1
InChIInChI=1S/C17H22N2O3S2/c1-3-7-16(20)18-17-19(12(2)13-8-5-4-6-9-13)14-10-24(21,22)11-15(14)23-17/h4-6,8-9,12,14-15H,3,7,10-11H2,1-2H3/b18-17-/t12-,14+,15+/m0/s1
InChIKeyHVYUWHCEOXWNOC-JGHBPBROSA-N
MW366.51 g/mol
LogP2.64
Rot. Bonds4

About N-[(3aR,6aS)-5,5-dioxo-3-[(1S)-1-phenylethyl]-3a,4,6,6a-tetrahydrothieno[3,4-d][1,3]thiazol-2-ylidene]butanamide

N-[(3aR,6aS)-5,5-dioxo-3-[(1S)-1-phenylethyl]-3a,4,6,6a-tetrahydrothieno[3,4-d][1,3]thiazol-2-ylidene]butanamide (PubChem CID 92670087) has the molecular formula C17H22N2O3S2 and a molecular weight of 366.51 g/mol. Its IUPAC name is N-[(3aR,6aS)-5,5-dioxo-3-[(1S)-1-phenylethyl]-3a,4,6,6a-tetrahydrothieno[3,4-d][1,3]thiazol-2-ylidene]butanamide.

Molecular Properties

Compound NameN-[(3aR,6aS)-5,5-dioxo-3-[(1S)-1-phenylethyl]-3a,4,6,6a-tetrahydrothieno[3,4-d][1,3]thiazol-2-ylidene]butanamide
PubChem CID92670087
Molecular FormulaC17H22N2O3S2
Molecular Weight366.51 g/mol
Exact Mass366.11
IUPAC NameN-[(3aR,6aS)-5,5-dioxo-3-[(1S)-1-phenylethyl]-3a,4,6,6a-tetrahydrothieno[3,4-d][1,3]thiazol-2-ylidene]butanamide
SMILESCCCC(=O)/N=C1\S[C@@H]2CS(=O)(=O)C[C@H]2N1[C@@H](C)c1ccccc1
InChIInChI=1S/C17H22N2O3S2/c1-3-7-16(20)18-17-19(12(2)13-8-5-4-6-9-13)14-10-24(21,22)11-15(14)23-17/h4-6,8-9,12,14-15H,3,7,10-11H2,1-2H3/b18-17-/t12-,14+,15+/m0/s1
InChIKeyHVYUWHCEOXWNOC-JGHBPBROSA-N
XLogP2.64
TPSA66.81 Ų
H-Bond Donors
H-Bond Acceptors4
Rotatable Bonds4
Heavy Atoms24
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500366.51
LogP ≤ 52.64
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'imine_1', 'substructure': 'N/A'}

Analyze N-[(3aR,6aS)-5,5-dioxo-3-[(1S)-1-phenylethyl]-3a,4,6,6a-tetrahydrothieno[3,4-d][1,3]thiazol-2-ylidene]butanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(3aR,6aS)-5,5-dioxo-3-[(1S)-1-phenylethyl]-3a,4,6,6a-tetrahydrothieno[3,4-d][1,3]thiazol-2-ylidene]butanamide?
The IUPAC name of N-[(3aR,6aS)-5,5-dioxo-3-[(1S)-1-phenylethyl]-3a,4,6,6a-tetrahydrothieno[3,4-d][1,3]thiazol-2-ylidene]butanamide (CID 92670087) is N-[(3aR,6aS)-5,5-dioxo-3-[(1S)-1-phenylethyl]-3a,4,6,6a-tetrahydrothieno[3,4-d][1,3]thiazol-2-ylidene]butanamide.
What is the SMILES notation for N-[(3aR,6aS)-5,5-dioxo-3-[(1S)-1-phenylethyl]-3a,4,6,6a-tetrahydrothieno[3,4-d][1,3]thiazol-2-ylidene]butanamide?
The canonical SMILES for N-[(3aR,6aS)-5,5-dioxo-3-[(1S)-1-phenylethyl]-3a,4,6,6a-tetrahydrothieno[3,4-d][1,3]thiazol-2-ylidene]butanamide is CCCC(=O)/N=C1\S[C@@H]2CS(=O)(=O)C[C@H]2N1[C@@H](C)c1ccccc1.
What is the InChIKey of N-[(3aR,6aS)-5,5-dioxo-3-[(1S)-1-phenylethyl]-3a,4,6,6a-tetrahydrothieno[3,4-d][1,3]thiazol-2-ylidene]butanamide?
The InChIKey is HVYUWHCEOXWNOC-JGHBPBROSA-N. The full InChI is InChI=1S/C17H22N2O3S2/c1-3-7-16(20)18-17-19(12(2)13-8-5-4-6-9-13)14-10-24(21,22)11-15(14)23-17/h4-6,8-9,12,14-15H,3,7,10-11H2,1-2H3/b18-17-/t12-,14+,15+/m0/s1.
What are the key properties of N-[(3aR,6aS)-5,5-dioxo-3-[(1S)-1-phenylethyl]-3a,4,6,6a-tetrahydrothieno[3,4-d][1,3]thiazol-2-ylidene]butanamide?
N-[(3aR,6aS)-5,5-dioxo-3-[(1S)-1-phenylethyl]-3a,4,6,6a-tetrahydrothieno[3,4-d][1,3]thiazol-2-ylidene]butanamide has a molecular weight of 366.51 g/mol, XLogP of 2.64, 4 rotatable bonds, 0 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(3aR,6aS)-5,5-dioxo-3-[(1S)-1-phenylethyl]-3a,4,6,6a-tetrahydrothieno[3,4-d][1,3]thiazol-2-ylidene]butanamide is sourced from PubChem (CID 92670087), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).